Ad is loading...
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
RSENX
Price
$19.58
Change
-$0.08 (-0.41%)
Updated
Nov 15 closing price
Ad is loading...

RNWFX vs RSENX

Header iconRNWFX vs RSENX Comparison
Open Charts RNWFX vs RSENXBanner chart's image
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
Victory Sophus Emerging Markets Y
Price$19.58
Change-$0.08 (-0.41%)
VolumeN/A
CapitalizationN/A
RNWFX vs RSENX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWFX vs. RSENX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Buy and RSENX is a StrongSell.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. RSENX (347M). RSENX pays higher dividends than RNWFX: RSENX (2.50) vs RNWFX (1.51). RNWFX was incepted earlier than RSENX: RNWFX (23 years) vs RSENX (16 years). RSENX is a more actively managed with annual turnover of: 72.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than RSENX: RNWFX (250) vs RSENX (1000000). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. RSENX (8.86). RNWFX return over 5 years is better than : 17.17 vs. RSENX (6.16).
RNWFXRSENXRNWFX / RSENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years16 years-
Gain YTD7.0994.930144%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B347M17,550%
Annual Yield % from dividends1.512.5060%
Returns for 1 year11.548.86130%
Returns for 3 years-14.55-15.7592%
Returns for 5 years17.176.16279%
Returns for 10 years41.0015.48265%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics